Yadan Xu

508 total citations
29 papers, 369 citations indexed

About

Yadan Xu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Yadan Xu has authored 29 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Yadan Xu's work include Multiple Myeloma Research and Treatments (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Yadan Xu is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Yadan Xu collaborates with scholars based in China, United States and South Korea. Yadan Xu's co-authors include Jianzhong Zhang, Weibin Huang, Yuming Jiang, Zhiwei Zhou, Shuhua Xi, Ruijiang Li, Jia Wu, Chuanxiang Chen, Qiang Yuan and Yue Hu and has published in prestigious journals such as Environmental Science & Technology, Blood and Chemosphere.

In The Last Decade

Yadan Xu

21 papers receiving 361 citations

Peers

Yadan Xu
Stephen D. Clark United States
Liming Yang China
David Lang Austria
Raquel Molina Spain
Joo-Hyun Nam South Korea
Georges Mjaess Lebanon
Qiufeng He China
Jonathan Unkart United States
Arian Mansur United States
Hakan Bozcuk Türkiye
Stephen D. Clark United States
Yadan Xu
Citations per year, relative to Yadan Xu Yadan Xu (= 1×) peers Stephen D. Clark

Countries citing papers authored by Yadan Xu

Since Specialization
Citations

This map shows the geographic impact of Yadan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yadan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yadan Xu more than expected).

Fields of papers citing papers by Yadan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yadan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yadan Xu. The network helps show where Yadan Xu may publish in the future.

Co-authorship network of co-authors of Yadan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yadan Xu. A scholar is included among the top collaborators of Yadan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yadan Xu. Yadan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Lin, Zirui Liu, Yadan Xu, et al.. (2025). Fluid therapy in acute pancreatitis comparing balanced solutions and normal saline: A systematic review, meta-analysis and trial sequential analysis. Hepatobiliary & pancreatic diseases international. 24(4). 371–380.
3.
4.
Tang, Hongchao, Danhong Wang, Da Qian, et al.. (2024). Xihuang pill suppresses breast cancer malignancy by inhibiting TGF-β signaling and acquires chemotherapy benefits. Journal of Ethnopharmacology. 337(Pt 3). 119000–119000. 4 indexed citations
5.
Qian, Da, Jie Qiu, Yadan Xu, et al.. (2024). Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer. Genomics. 116(5). 110930–110930.
6.
Huang, Mingyao, et al.. (2024). Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy. Pharmacological Research. 208. 107354–107354. 1 indexed citations
7.
Wang, Danhong, Xiaozhen Liu, Yadan Xu, et al.. (2024). Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways. Cancer Cell International. 24(1). 214–214. 10 indexed citations
8.
9.
Wang, Danhong, Yadan Xu, Jie Qiu, et al.. (2023). Gut microbiome causal impacts on the prognosis of breast cancer: a Mendelian randomization study. BMC Genomics. 24(1). 497–497. 20 indexed citations
10.
Xu, Yadan, Yi Dong, Feng Mao, et al.. (2023). Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma. Diagnostics. 13(7). 1337–1337. 4 indexed citations
11.
12.
Jiang, Yuming, Jia Wu, Chuanxiang Chen, et al.. (2020). Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer. Annals of Oncology. 31(6). 760–768. 128 indexed citations
13.
14.
Dong, Hua, Junying Xu, Yadan Xu, et al.. (2019). OA03.01 A Non-Randomized, Open-Label, Prospective, Multicenter Study of Apatinib as Second-Line and Later-Line Therapy in Patients with ES-SCLC. Journal of Thoracic Oncology. 14(10). S210–S211. 2 indexed citations
15.
Fu, Yang‐Xin, et al.. (2019). Improved display of abdominal contrast-enhanced MRA using gadobutrol: comparison with Gd-DTPA. Clinical Radiology. 74(12). 978.e1–978.e7. 3 indexed citations
16.
17.
Rizzo, Maria Teresa, Yadan Xu, Sumeet Panjabi, & Ike Iheanacho. (2014). A Systematic Literature Review of the Economic Burden in Multiple Myeloma. Value in Health. 17(7). A628–A628. 7 indexed citations
18.
Rizzo, Manfredi, Yadan Xu, Sumeet Panjabi, & Ike Iheanacho. (2014). A Systematic Literature Review of the Humanistic Burden of Multiple Myeloma. Value in Health. 17(7). A537–A537. 2 indexed citations
19.
20.
Xu, Yadan, et al.. (1988). Glucose-6-phosphate dehydrogenase variants and their frequency in Guangdong, China. Human Genetics. 80(4). 385–388. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen D. Clark Breakdown of academic impact, for papers by Liming Yang Breakdown of academic impact, for papers by David Lang Breakdown of academic impact, for papers by Raquel Molina Breakdown of academic impact, for papers by Joo-Hyun Nam Breakdown of academic impact, for papers by Georges Mjaess Breakdown of academic impact, for papers by Qiufeng He Breakdown of academic impact, for papers by Jonathan Unkart Breakdown of academic impact, for papers by Arian Mansur Breakdown of academic impact, for papers by Hakan Bozcuk
Rankless by CCL
2026